Sputnik V will be manufactured by five pharma firms in the country. (File)
New Delhi:
Russia s Sputnik V, the third Covid vaccine to be cleared for use in India, is effective against mutant strains, the Russian Direct Investment Fund (RDIF) has said.
Sputnik V will be manufactured by five pharma firms in the country and 850 million doses will be produced in a year. Limited doses will be available by the end of April.
The Russian wealth fund RDIF s CEO Kirill Dmitriev told NDTV Sputnik has the same effectiveness against the British strain as against many other variants and also the original virus.
Novel Coronavirus Jumped From Bats To Humans With Very Little Change : Scientists
The new study revealed that for the first 11 months of the Covid-19 pandemic, there has been very little important genetic change observed in the coronavirus.
Representational Image Outlook Web Bureau 2021-03-14T15:54:44+05:30 Novel Coronavirus Jumped From Bats To Humans With Very Little Change : Scientists outlookindia.com 2021-03-14T16:00:57+05:30
A new study suggests that the ability of the novel coronavirus to spread from one person to another likely evolved in the flying mammal prior to it jumping to its new human host. It analysed that the progenitor of the virus underwent very little change to adapt to humans from bats
To improve the performance of our website, show the most relevant news products and targeted advertising, we collect technical impersonal information about you, including through the tools of our partners. You can find a detailed description of how we use your data in our Privacy Policy. For a detailed description of the technologies, please see the Cookie and Automatic Logging Policy.
By clicking on the Accept & Close button, you provide your explicit consent to the processing of your data to achieve the above goal.
You can withdraw your consent using the method specified in the Privacy Policy.
Accept & Close
Sputnik International
Head of U.K. program that tracks COVID-19 variants says virus may have reached ‘plateau’ in terms of evolution Bookmark Please log in to listen to this story. Also available in French and Mandarin. Log In Create Free Account
Getting audio file . This translation has been automatically generated and has not been verified for accuracy. Full Disclaimer
Kirsty Wigglesworth/The Associated Press
The head of a British program that tracks variants of the COVID-19 virus says it may have hit “peak fitness” in terms of its ability to spread and evade vaccines.
“We seem to have reached a relative plateau, if you like, of what the virus is doing in terms of evolution,” said Sharon Peacock, director of the COVID-19 Genomics UK consortium, or COG-UK. “It could be that there’s a point at which the virus has kind of optimal fitness in terms of transmissibility and evasion of immunity, and it may be that there will be a pause. What I don’t know is what happens after tha
A BMC health workers checks swab tests of construction workers in the city
MUMBAI: Dr Subhash Salunkhe, an advisor to the Maharashtra government, has termed the ongoing viral activity in Amravati and Akola districts “extremely unusual” and the rise in cases “exponential”. The only upside till now, said Dr Salunkhe, is the spread appears to be in “isolated small pockets”.
State government health officials said genomic sequencing of four patients from Amravati showed “unique mutations”, including E484Q, which is similar to a mutation (E484K) found in South African and Brazilian variants. Four samples from Yavatmal, too, showed unique mutations, including the N440K that first emerged in the neighbouring Andhra Pradesh.